Evidence map›Paper›PMID 42909118›Full record

ArticleFrontiers in microbiology2026

Fluoroquinolone resistance-associated determinants in ciprofloxacin-susceptible

Cheikh Ibrahima Lo, Elhadj Aly Niang, Ousmane Sadio, Safietou Sankhe, Adja Bousso Guèye, Mouhamed Kane, Marie Odile Ndiaye, Maimouna Mbanne, Jaubert Yelkouni, Sokhna Ndongo and 5 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Cheikh Ibrahima LoPôle Microbiologie, Institut Pasteur de Dakar, Dakar, Senegal.
Elhadj Aly NiangPôle Microbiologie, Institut Pasteur de Dakar, Dakar, Senegal.
Ousmane SadioPôle Microbiologie, Institut Pasteur de Dakar, Dakar, Senegal.
Safietou SankhePlateforme de Séquençage du Pôle de Virologie, Institut Pasteur de Dakar, Dakar, Senegal.
Adja Bousso GuèyePôle Microbiologie, Institut Pasteur de Dakar, Dakar, Senegal.
Mouhamed KaneÉcole Doctorale des Sciences de la Vie, de la Santé et de l'Environnement, Université Cheikh Anta Diop de Dakar, Dakar, Senegal.
Marie Odile NdiayePôle Microbiologie, Institut Pasteur de Dakar, Dakar, Senegal.
Maimouna MbannePlateforme de Séquençage du Pôle de Virologie, Institut Pasteur de Dakar, Dakar, Senegal.
Jaubert YelkouniPôle Microbiologie, Institut Pasteur de Dakar, Dakar, Senegal.
Sokhna NdongoPôle Microbiologie, Institut Pasteur de Dakar, Dakar, Senegal.
Fatime Poulo LyPôle Microbiologie, Institut Pasteur de Dakar, Dakar, Senegal.
Abdoul Aziz WanePôle Microbiologie, Institut Pasteur de Dakar, Dakar, Senegal.
Cheikh FallPôle Microbiologie, Institut Pasteur de Dakar, Dakar, Senegal.
Moussa Moise DiagnePlateforme de Séquençage du Pôle de Virologie, Institut Pasteur de Dakar, Dakar, Senegal.
Yakhya DieyePôle Microbiologie, Institut Pasteur de Dakar, Dakar, Senegal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Fluoroquinolones remain important therapeutic options for shigellosis, but the accumulation of chromosomal and plasmid-mediated resistance determinants threatens their continued effectiveness. Genomic data on fluoroquinolone resistance-associated determinants in Methods: Stool specimens collected from patients with acute diarrhea were cultured for Results: Among 900 diarrheal stool specimens, 22 Conclusion: These findings demonstrate that phenotypic susceptibility to ciprofloxacin may coexist with fluoroquinolone resistance-associated genomic determinants in clinical

Indexed as

antimicrobial resistanceciprofloxacinfluoroquinolone resistancegyrAqnrS1SenegalShigellawhole-genome sequencing

Identifiers

PMID42909118
PMCPMC13683774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.